文献速递乳腺癌

橄榄油摄入与乳腺癌风险:Moli-sani研究的前瞻性结果及观察性研究和随机临床试验的系统综述

Olive oil consumption and risk of breast cancer: Prospective results from the Moli-sani Study, and a systematic review of observational studies and randomized clinical trials.
PubMed 文献 · Eur J Cancer · 2025-05-24

在Moli-sani队列11442名意大利成年女性中,最高橄榄油摄入(>3汤匙/日)与总体、绝经前和绝经后乳腺癌风险的多变量校正HR分别为0.71、0.80和0.70,均未达统计学显著;每日增加1汤匙橄榄油与ER和PR乳腺癌风险降低相关(HR=0.32)。系统综述纳入13项观察性研究和1项RCT,病例对照研究和RCT提示保护作用,纵向研究未报告关联。

要点

  • 最高橄榄油摄入(>3汤匙/日)与总体乳腺癌风险HR=0.71(95%CI 0.48-1.05),未达统计学显著。
  • 每日增加1汤匙橄榄油与ER和PR乳腺癌风险降低相关(HR=0.32;95%CI 0.13-0.77)。
  • 系统综述中病例对照研究更常报告保护性关联,前瞻性研究未一致支持该发现。

核心结论

  • Moli-sani研究结果提示橄榄油摄入与激素受体阴性乳腺癌风险呈负相关,尤其是ER亚型,但对总体乳腺癌风险的结果不确定。
  • 系统综述显示病例对照研究更常报告保护性关联,而前瞻性研究未一致支持该发现。

研究设计与样本

  • 对Moli-sani研究(2005-2010年)纳入的11442名女性(平均年龄54.7±11.6岁)进行纵向分析,采用Cox比例风险模型估计乳腺癌风险。
  • 系统综述检索Scopus、EMBASE、PubMed和MEDLINE数据库截至2024年10月,纳入观察性研究和随机对照试验(RCT)。

主要发现

  • 与较低橄榄油摄入(≤2汤匙/日)相比,最高摄入(>3汤匙/日)与总体乳腺癌风险的多变量校正HR为0.71(95%CI 0.48-1.05),绝经前为0.80(95%CI 0.28-2.28),绝经后为0.70(95%CI 0.46-1.08)。
  • 每日增加1汤匙橄榄油与ER和PR乳腺癌风险降低相关(HR=0.32;95%CI 0.13-0.77),尤其是ER病例(HR=0.32;95%CI 0.15-0.69)。
  • 与最低摄入类别相比,最高橄榄油摄入与HER2-乳腺癌发病风险降低相关(HR=0.54;95%CI 0.31-0.96)。
  • 系统综述纳入13项观察性研究(11项病例对照研究和2项前瞻性研究)和1项RCT。
  • 病例对照研究和RCT提示橄榄油摄入相关保护效应,纵向研究报告无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Breast cancer (BC) is the leading cause of cancer-related death among women worldwide. Olive oil, rich in monounsaturated fats and polyphenols, has been linked to a reduced BC risk, but epidemiological evidence remains limited. This study examined the association between olive oil consumption and BC risk in a large cohort of adult Italian women and conducted a systematic review on this association. METHODS: Longitudinal analyses were performed on 11,442 women (mean age 54.7 ± 11.6 years) enrolled in the Moli-sani Study (2005-2010). Cox proportional hazard models were used to estimate BC risk in relation to olive oil consumption. A systematic review was conducted by searching Scopus, EMBASE, PubMed, and MEDLINE databases up to October 2024 for observational studies and RCTs. RESULTS: Compared with lower olive oil consumption (≤2 tbsp./day), multivariable-adjusted HRs associated with highest intake (>3 tbsp./d) for overall, premenopausal, and postmenopausal BC were 0.71(95 %CI 0.48-1.05), 0.80 (95 %CI 0.28-2.28), and 0.70 (95 %CI 0.46-1.08), respectively. An increase of 1-tbsp./d of olive oil was associated with a lower risk of ER and PR breast cancers (HR=0.32; 95 %CI 0.13-0.77), particularly ER cases (HR=0.32; 95 %CI 0.15-0.69); additionally, a lowered hazard of HER2- BC incidence was observed at highest consumption of olive oil compared to the bottom category (HR=0.54; 95 %CI 0.31-0.96). The systematic review included 13 observational studies (11 case-control and 2 prospective) and 1 RCT. While case-control studies and the RCT suggested a protective effect associated with olive oil consumption, longitudinal studies reported no association. CONCLUSIONS: Findings from the Moli-sani Study suggest an inverse association between olive oil consumption and the risk of hormone receptor-negative breast cancers, particularly ER subtype, while results were inconclusive for overall BC risk. The systematic review revealed that case-control studies more frequently reported a protective association, whereas prospective studies did not consistently support this finding.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Ruggiero E, Sharma S, Di Castelnuovo A, et al. Olive oil consumption and risk of breast cancer: Prospective results from the Moli-sani Study, and a systematic review of observational studies and randomized clinical trials. Eur J Cancer. 2025. PMID: 40449295. doi:10.1016/j.ejca.2025.115520

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。